The Director of Analytical and Formulation Development at Denali Therapeutics is responsible for providing strategic technical leadership in late-phase analytical development and characterization activities for large molecules. This role involves oversight of control strategy development and implementation at manufacturing and QC testing sites, ensuring the delivery of high-quality therapeutics for neurodegenerative diseases. The position requires collaboration with cross-functional teams and external partners to drive analytical development and support regulatory submissions.